awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37022524-79AB65ED-6E69-406F-B502-6F91ACE18EB4
Q37022524-79AB65ED-6E69-406F-B502-6F91ACE18EB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-79AB65ED-6E69-406F-B502-6F91ACE18EB4
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
P2860
Q37022524-79AB65ED-6E69-406F-B502-6F91ACE18EB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-79AB65ED-6E69-406F-B502-6F91ACE18EB4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f92d4f27d21d2f96a2181e2f2ef94349db3999bb
P2860
What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?